Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
20m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
20m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
20m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
20m agoFirst Quantum Minerals Reports First Quarter 2026 Results
21m agoDistrict Metals Announces $10 Million Private Placement Financing
Tempest Therapeutics Inc logo

Tempest Therapeutics Inc

About

Tempest Therapeutics Inc (NASDAQ:TPST) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T
Apr 14 2026
Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts
Mar 30 2026
Tempest Reports Year End 2025 Financial Results and Provides Business Update
Mar 23 2026
Tempest Therapeutics Announces Up To $6 Million Private Placement
Mar 11 2026
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026

Financials

Revenue
$0
Market Cap
$22.81 M
EPS
-6.33

Community Chat

Ask AI

6ix6ixAIEvents